NASDAQ Companies - Capital Market

Page: 9 of 14
Exchange:   NASDAQ
Displaying 401-450 of 659 results Download this list
Name Symbol Market Cap ADR TSO Country IPO Year Subsector
New York Mortgage Trust, Inc. n/a United States n/a Finance: Consumer Services
Newtek Business Services Inc. $102.41M United States n/a Business Services
NF Energy Saving Corporation $16.7M China n/a Metal Fabrications
Nortech Systems Incorporated $14.43M United States n/a Industrial Machinery/Components
Northwest Biotherapeutics, Inc. $331.44M United States 2012 Major Pharmaceuticals
Northwest Biotherapeutics, Inc. n/a United States n/a Major Pharmaceuticals
Novogen Limited $7.64M 2,342,104 Australia n/a Major Pharmaceuticals
NV5 Holdings, Inc. $56.09M United States 2013 Other Consumer Services
NV5 Holdings, Inc. n/a United States 2013 Other Consumer Services
NVE Corporation $330.84M United States n/a Semiconductors
NXT-ID Inc. $52.43M United States n/a n/a
NXT-ID Inc. n/a United States n/a n/a
Nymox Pharmaceutical Corporation $166.39M Canada n/a Biotechnology: In Vitro & In Vivo Diagnostic Substances
Oak Valley Bancorp (CA) $78.86M United States n/a Major Banks
OBA Financial Services, Inc. $90.94M United States 2010 Savings Institutions
Ocean Bio-Chem, Inc. $27.81M United States n/a Specialty Chemicals
Oconee Federal Financial Corp. $103.3M n/a 2011 Savings Institutions
Oculus Innovative Sciences, Inc. $19.24M United States 2007 Medical/Dental Instruments
Odyssey Marine Exploration, Inc. $94.6M United States n/a Marine Transportation
Ohr Pharmaceuticals, Inc. $196.17M n/a n/a Major Pharmaceuticals
Old Line Bancshares, Inc. $156.6M United States n/a Major Banks
Old Point Financial Corporation $74.39M United States n/a Major Banks
OncoGenex Pharmaceuticals Inc. $64.89M United States n/a Biotechnology: In Vitro & In Vivo Diagnostic Substances
Oncolytics Biotech, Inc. $111.06M Canada n/a Major Pharmaceuticals
One Horizon Group, Inc. $92.18M Switzerland n/a Telecommunications Equipment
Onvia, Inc. $32.99M United States 2000 Business Services
Opexa Therapeutics, Inc. $35.25M United States n/a Major Pharmaceuticals
OptimumBank Holdings, Inc. $12.23M United States n/a Major Banks
Oramed Pharmaceuticals Inc. $88.51M Israel n/a Major Pharmaceuticals
Orbit International Corporation $13.37M United States n/a Industrial Machinery/Components
Orrstown Financial Services Inc $132.67M United States n/a Major Banks
Ossen Innovation Co., Ltd. $5.39M 6,061,459 China 2010 Steel/Iron Ore
Otelco Inc. $14.9M United States n/a Telecommunications Equipment
Overland Storage, Inc. $60.4M United States 1997 Electronic Components
Oxbridge Re Holdings Limited $41.94M Cayman Islands 2014 Property-Casualty Insurers
Oxbridge Re Holdings Limited n/a Cayman Islands 2014 Property-Casualty Insurers
OXiGENE, Inc. $46.17M United States n/a Biotechnology: Biological Products (No Diagnostic Substances)
Oxygen Biotherapeutics, Inc. $114.12M n/a n/a Biotechnology: Commercial Physical & Biological Resarch
Pacific Ethanol, Inc. $438.95M United States n/a Major Chemicals
Palmetto Bancshares, Inc. (SC) $174.86M United States n/a Major Banks
Park City Group, Inc. $180.99M United States n/a EDP Services
Parke Bancorp, Inc. $70.46M United States n/a Major Banks
ParkerVision, Inc. $127.09M United States 1993 Radio And Television Broadcasting And Communications Equipment
Pathfinder Bancorp, Inc. $37.17M United States n/a Banks
Peerless Systems Corporation $12.45M United States 1996 Computer Software: Prepackaged Software
Peoples Federal Bancshares, Inc. $127.14M United States 2010 Banks
Peoples Financial Corporation $68.96M United States n/a Major Banks
Peregrine Pharmaceuticals Inc. $269.26M United States n/a Major Pharmaceuticals
Peregrine Pharmaceuticals Inc. $17.17M United States n/a Major Pharmaceuticals
Perfumania Holdings, Inc $98.24M United States n/a Other Specialty Stores
*IPO year information is not available for stocks prior to 1970.